MarketPulse
I

$INO

52 articles found
0 positive
52 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Ramaco Resources Faces Major Fraud Allegations; Class Action Lawsuit Filed Over Wyoming Mine Claims

Pomerantz Law Firm files class action against $METC following Wolfpack Research allegations of fraudulent Brook Mine operations, sparking 9.57% stock decline.
METCMETCBMETCIMETCZRR+1securities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Smart Digital Stock Crashes 86%, Triggering Class Action Lawsuit Over Alleged Fraud

$SDM plunges 86.4% after SEC suspension; class action lawsuit filed against Smart Digital Group and others for alleged securities fraud and social media market manipulation.
SDMRRINOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

BellRing Brands Faces Class Action Lawsuit Over Misleading Earnings Guidance

Pomerantz Law Firm sues BellRing Brands ($BRBR) for securities fraud over allegedly misleading earnings guidance and undisclosed inventory hoarding and capacity constraints.
BRBRRRINOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Law Offices Of Howard G. Smith

Four Major Companies Face Securities Fraud Lawsuits; Investors Eye April 2026 Deadlines

Four companies face securities fraud lawsuits alleging false business disclosures. Investors have until April 2026 to file lead plaintiff motions.
KDORCLORCLpDINOPSFEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Schall Law Firm

Inovio Pharmaceuticals Hit with Securities Fraud Lawsuit Over Device Claims

Inovio Pharmaceuticals faces class action securities fraud lawsuit alleging false statements about manufacturing capabilities and regulatory timelines. Investors have until April 7, 2026 to join.
INOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Inovio Faces Securities Class Action Over Device Defects, Missed Regulatory Timelines

Rosen Law Firm files securities class action against Inovio Pharmaceuticals ($INO) alleging misleading statements on manufacturing deficiencies and overstated regulatory prospects. Lead plaintiff deadline April 7, 2026.
INOsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Camping World Under Fire in Securities Lawsuit Over Alleged Inventory, Demand Misstatements

Rosen Law Firm files class action lawsuit against Camping World Holdings over alleged misstatements regarding inventory management and consumer demand projections.
CWHINOTCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Inovio Faces Class Action Over Alleged Misstatements on Device Manufacturing and FDA Timeline

Class action lawsuit filed against Inovio Pharmaceuticals for allegedly making false statements about CELLECTRA device manufacturing and INO-3107 FDA submission timeline between October 2023 and December 2025.
INOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Class Action Lawsuits Filed Against $POMD and $INO Over Fraud Allegations

Class actions filed against PomDoctor for stock promotion fraud and Inovio for misleading regulatory claims. Inovio stock plunged 24.45% after FDA rejection.
INOPOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Inovio Faces Securities Class Action Over Undisclosed Manufacturing Delays, FDA Review Setbacks

Law firm Levi & Korsinsky seeks investors in Inovio Pharmaceuticals securities class action alleging failure to disclose manufacturing delays and FDA's standard review decision.
INOsecurities class actionFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Inovio Faces Securities Lawsuit Over Manufacturing Claims and Regulatory Missteps

Rosen Law Firm urges $INO investors to join class action lawsuit alleging false statements about manufacturing deficiencies and regulatory prospects.
INOsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Rosen Law Targets Ramaco Resources in Securities Fraud Case Over Brook Mine Claims

Rosen Law Firm pursues securities class action against $METC, alleging false statements about Brook Mine development progress. Lead plaintiff deadline set for March 31, 2026.
APOAPOSAPOpAMETCMETCB+3securities class actionlead plaintiff
GlobeNewswire Inc.GlobeNewswire Inc.··Schall Law Firm

Inovio Faces Securities Fraud Lawsuit Over Manufacturing Claims and BLA Delays

Schall Law Firm files securities fraud class action against $INO for allegedly making false statements about manufacturing deficiencies and regulatory filing timelines.
INOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Inovio Faces Securities Fraud Lawsuit Over INO-3107 Misstatements

Class action lawsuit filed against $INO for allegedly false statements about INO-3107 treatment and CELLECTRA device. Lead plaintiff deadline is April 7, 2026.
INOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Pomerantz Files Securities Fraud Class Action Against Inovio Pharmaceuticals

Pomerantz files class action against Inovio Pharmaceuticals for alleged securities fraud related to false FDA approval statements and concealed manufacturing deficiencies.
PLUGENPHINOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Inovio Hit With Securities Lawsuit Over FDA Approval Claims

Levi & Korsinsky files class action against Inovio Pharmaceuticals alleging management misrepresented FDA accelerated approval eligibility for lead candidate, causing stock decline.
INOsecurities class actionBiologics License Application
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Inovio Investors Urged to File Claims Before April Deadline in Securities Litigation

Rosen Law Firm notifies Inovio investors of securities class action with April 7, 2026 lead plaintiff deadline, citing alleged false statements on manufacturing and regulatory matters.
INOinvestor lossessecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Inovio Pharmaceuticals Faces Class Action Over FDA Rejection and Device Claims

Inovio Pharmaceuticals faces class action lawsuit over alleged false statements regarding manufacturing defects and regulatory prospects after FDA rejected accelerated approval, causing 24% stock decline.
INOclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Law Offices Of Howard G. Smith

Four Public Companies Face Securities Fraud Class Actions; Investor Deadlines Approaching

Four major companies face securities fraud lawsuits for misleading investors on AI spending, financial disclosures, and manufacturing claims. Investor filing deadlines approaching.
KDORCLORCLpDINOPSFEsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Inovio Pharmaceuticals Faces Regulatory Headwinds Amid Capital Constraints

Inovio Pharmaceuticals faces FDA rejection of its lead drug candidate and mounting cash constraints, raising questions about the biotech firm's long-term viability without revenue-generating products.
INOFDA approvalbiotech